Additionally, higher serum CHI3L1 levels were linked to shorter overall survival (OS) and early mortality among metastatic PCa patients undergoing ADT15 and docetaxel chemotherapy.16 The gene discussed is CHI3L1; the disease is posterior cortical atrophy.